19951002
 Merck's Drug For Bones Gets FDA Approval   By By Jerry E. Bishop, The Wall Street Journal,  Oct 3, 1995  Educating women and their doctors about osteoporosis, the bone-thinning disease, is expected to be a key part of a major marketing effort the big drug maker will launch later this month for its Fosamax brand of alendronate. Merck said yesterday that it had finally received its long-expected clearance from the Food and Drug Administration to begin selling Fosamax for the treatment of osteoporosis.   
